Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis

por Kholodenko, Irina V., Yarygin, Konstantin N.
Publicado 2023

Cellular Mechanisms of Liver Regeneration and Cell-Based Therapies of Liver Diseases

por Kholodenko, Irina V., Yarygin, Konstantin N.
Publicado 2017

The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress

por Kholodenko, Irina V., Kholodenko, Roman V., Yarygin, Konstantin N.
Publicado 2023

Cell-based therapies of liver diseases: age-related challenges

por Yarygin, Konstantin N, Lupatov, Alexei Y, Kholodenko, Irina V
Publicado 2015

Apoptotic MSCs and MSC-Derived Apoptotic Bodies as New Therapeutic Tools

por Kholodenko, Irina V., Kholodenko, Roman V., Majouga, Alexander G., Yarygin, Konstantin N.
Publicado 2022

Neuroblastoma Origin and Therapeutic Targets for Immunotherapy

por Kholodenko, Irina V., Kalinovsky, Daniel V., Doronin, Igor I., Deyev, Sergey M., Kholodenko, Roman V.
Publicado 2018

Mesenchymal Stem Cells in the Adult Human Liver: Hype or Hope?

por Kholodenko, Irina V., Kurbatov, Leonid K., Kholodenko, Roman V., Manukyan, Garik V., Yarygin, Konstantin N.
Publicado 2019

Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood–Brain Barrier?

por Yarygin, Konstantin N., Namestnikova, Daria D., Sukhinich, Kirill K., Gubskiy, Ilya L., Majouga, Alexander G., Kholodenko, Irina V.
Publicado 2021

Ganglioside GD2 in reception and transduction of cell death signal in tumor cells

por Doronin, Igor I, Vishnyakova, Polina A, Kholodenko, Irina V, Ponomarev, Eugene D, Ryazantsev, Dmitry Y, Molotkovskaya, Irina M, Kholodenko, Roman V
Publicado 2014

Resistance of Human Liver Mesenchymal Stem Cells to FAS-Induced Cell Death

por Kholodenko, Irina V., Gisina, Alisa M., Manukyan, Garik V., Majouga, Alexander G., Svirshchevskaya, Elena V., Kholodenko, Roman V., Yarygin, Konstantin N.
Publicado 2022

Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4

por Kalinovsky, Daniel V., Kholodenko, Irina V., Svirshchevskaya, Elena V., Kibardin, Alexey V., Ryazantsev, Dmitry Yu., Rozov, Fedor N., Larin, Sergey S., Deyev, Sergey M., Kholodenko, Roman V.
Publicado 2023

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors

por Kalinovsky, Daniel V, Kibardin, Alexey V, Kholodenko, Irina V, Svirshchevskaya, Elena V, Doronin, Igor I, Konovalova, Mariya V, Grechikhina, Maria V, Rozov, Fedor N, Larin, Sergey S, Deyev, Sergey M, Kholodenko, Roman V
Publicado 2022

Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells

por Kalinovsky, Daniel V., Kholodenko, Irina V., Kibardin, Alexey V., Doronin, Igor I., Svirshchevskaya, Elena V., Ryazantsev, Dmitriy Y., Konovalova, Maria V., Rozov, Fedor N., Larin, Sergey S., Deyev, Sergey M., Kholodenko, Roman V.
Publicado 2023

TRIM28 Is a Novel Regulator of CD133 Expression Associated with Cancer Stem Cell Phenotype

por Kim, Yan S., Potashnikova, Daria M., Gisina, Alisa M., Kholodenko, Irina V., Kopylov, Arthur T., Tikhonova, Olga V., Kurbatov, Leonid K., Saidova, Aleena A., Tvorogova, Anna V., Kholodenko, Roman V., Belousov, Pavel V., Vorobjev, Ivan A., Zgoda, Victor G., Yarygin, Konstantin N., Lupatov, Alexey Yu.
Publicado 2022